FDA approves Dompé’s Oxervate for rare eye disease treatment

pharmanewsdaily- August 23, 2018 0

Dompé farmaceutici, an Italian pharmaceutical company, has achieved a milestone with the U.S. Food and Drug Administration (FDA) approval of Oxervate (cenegermin) eye drops for ... Read More